ImmunityBio
IBRX
#2494
Rank
S$9.19 B
Marketcap
S$8.64
Share price
7.03%
Change (1 day)
216.23%
Change (1 year)

ImmunityBio (IBRX) - Total liabilities

Total liabilities on the balance sheet as of June 2026 : S$2.15 Billion

According to ImmunityBio's latest financial reports the company's total liabilities are S$2.15 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

ImmunityBio - Total liabilities on balance sheet (from 2020 to 2026)

Total liabilities by year

Year Total liabilities Change
2025-12-31S$1.28 B8.6%
2024-12-31S$1.18 B-17.78%
2023-12-31S$1.44 B32.26%
2022-12-31S$1.08 B12.98%
2021-12-31S$0.96 B114.33%
2020-12-31S$0.44 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
ORIC Pharmaceuticals
ORIC
S$30.21 M-98.60%๐Ÿ‡บ๐Ÿ‡ธ USA